Atlas Trials

Safety and Tolerability Study of IV ST266 in COVID-19 Subjects

Clinical trial NCT04720378 · COMPLETED

Trial details

NCT number
NCT04720378
Sponsor
Noveome Biotherapeutics, formerly Stemnion
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cytokine Release Syndrome
Start date
2021-05-30
Primary completion
2022-05-03
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.